RANO MATHEW: Open Payments
NPI 1972694297 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,058 in 59 payments from 18 companies in 2025. Trend: 2023 $3,006 · 2024 $4,380 · 2025 $2,058
Food & beverage: $2,058
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $430 |
| Axsome Therapeutics, Inc. | 7 | $235 |
| Neurocrine BioSciences, Inc. | 6 | $200 |
| E.R. Squibb & Sons, L.L.C. | 5 | $193 |
| Janssen Pharmaceuticals, Inc | 4 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $157 |
| Alkermes, Inc. | 2 | $136 |
| Otsuka America Pharmaceutical, Inc. | 2 | $105 |
| Luye Pharma (USA) Ltd. | 2 | $88 |
| Indivior Inc. | 3 | $62 |
Products named: FANAPT, Auvelity, INGREZZA, COBENFY, CAPLYTA, LYBALVI, INVEGA SUSTENNA, REXULTI.
Industry payments across NC — which companies pay providers there.
